Discover investment opportunities in Small Pharmaceutical Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Small Pharmaceutical Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Small Pharmaceutical Stocks using our Smart AI Filter.
7 stocks found for "Small Pharmaceutical Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.39 | ±93.2% | -1.1 | 0.00% | |||
1.10 | ±61.5% | 46.4 | 0.00% | |||
0.77 | ±39.0% | 16.9 | 0.00% | |||
0.95 | ±90.4% | -0.8 | 0.00% | |||
1.07 | ±65.7% | 5.6 | 0.00% | |||
0.96 | ±55.6% | -223.5 | 0.00% | |||
1.05 | ±70.4% | 4.9 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How do small pharmaceutical stocks like ACAD and AMRN perform in volatile markets?
A: Small pharma stocks, like ACAD and AMRN, often experience higher volatility due to clinical trial results and regulatory decisions. These factors can lead to significant price swings depending on outcomes.
Q: What are the growth prospects for emerging pharmaceutical companies like FOLD and XERS?
A: Companies like FOLD and XERS may show strong growth potential due to innovative drug pipelines. However, their success heavily relies on R&D achievements and successful market approval of new drugs.
Q: Are there any dividend-paying small pharmaceutical stocks on the screener page?
A: Small pharmaceutical companies like those on this screener generally focus on growth rather than paying dividends, as they often reinvest earnings into research and development.
Q: What role does location play for companies like IVER and LGND in drug distribution?
A: Location can impact drug distribution logistics, access to market, and strategic partnerships. It may influence operational costs and availability of skilled labor, affecting overall competitiveness.
Q: How important is FDA approval for firms like BLRX and CRTX?
A: FDA approval is crucial for BLRX and CRTX as it determines market access and potential revenue from new drugs. Without approval, their products cannot be legally sold or marketed in the U.S.
Q: Can companies like ANIP benefit from strategic partnerships?
A: Companies like ANIP may find strategic partnerships beneficial for scaling operations, accessing new markets, or enhancing R&D capabilities, potentially speeding up drug development and market entry.
The mean of analysts' price targets for KALA BIO (KALA) points to a 74.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read more